Clinical trials
Active, not recruiting Carcinoma, Transitional Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
76 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 9 |
| 2018 | 2 |
| 2019 | 7 |
| 2020 | 8 |
| 2021 | 10 |
| 2022 | 11 |
| 2023 | 10 |
| 2024 | 5 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 76 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 9 |
| M.D. Anderson Cancer Center | 8 |
| Fox Chase Cancer Center | 4 |
| Jonsson Comprehensive Cancer Center | 3 |
| Memorial Sloan Kettering Cancer Center | 3 |
| BeiGene | 2 |
| Dana-Farber Cancer Institute | 2 |
| EMD Serono Research & Development Institute, Inc. | 2 |
| H. Lee Moffitt Cancer Center and Research Institute | 2 |
| ImmunityBio, Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Transitional Cell | 76 |
| Urinary Bladder Neoplasms | 35 |
| Carcinoma, Renal Cell | 17 |
| Melanoma | 13 |
| Carcinoma, Non-Small-Cell Lung | 11 |
| Colorectal Neoplasms | 10 |
| Ovarian Neoplasms | 10 |
| Uterine Cervical Neoplasms | 9 |
| Carcinoma, Hepatocellular | 8 |
| Neoplasm Metastasis | 8 |
Trials
Showing 1 to 25 of 76. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.